Send feedback

CLN3 p.Ser69=

c.207G>A · rs551476103 · VCV386233

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0134%, eas)
Conditions
1
neuronal ceroid lipofuscinosis

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.026GERP -3.3, phastCons 0.004
Overall
CADD1.312PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0134% East Asian · 6/44,848 alleles
Filtering AF 0.00679% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00524%
Overall 0.00161% 26/1,612,804 alleles · ultra-rare
Ancestry group Frequency 1 in
East Asiangrpmax 0.0134% 7,475
South Asian 0.0121% 8,251
Remaining individualsnot grpmax-eligible 0.0016% 62,450
European (non-Finnish) 0.000678% 147,434

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CLN3
Protein
p.Ser69=
Coding
c.207G>A
MANE Select
NM_001042432
dbSNP
rs551476103
Type
single nucleotide variant
Location
chr16:28489305 (GRCh38)
Gene constraint
LOEUF 1.022 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 81.81
Full CLN3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cln3-p-ser69 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown